Treatments

Increase in Treatment Options Leads to Greater Quality of Life

Kenny Capps, Tulio Rodriguez, MD, Denise Levitan, MD

First and Second-Line Treatment Protocols for Multiple Myeloma

Cindy Chmielewski, Alfred Garfall, MD, Edward Stadtmauer, MD

How Accessible is CAR T-Cell Therapy?

Andrew Schorr, Nina Shah, MD

Multiple Myeloma Treatment Overview

Andrew Schorr, Shambavi Richard, MD, Joshua Harris, MD

What Role Does Dexamethasone Play in Myeloma Treatment?

Jack Aiello, Nina Shah, MD, Thomas Martin, MD

Biochemical Relapse in Multiple Myeloma Patients

Cindy Chmielewski, Shebli Atrash, MD, Mauricio Pineda-Roman, MD

Our Multiple Myeloma: Communicating With Your Care Team

Tara Gregory, MD

Facing Forward: Latest News on Clinical Trials and Treatments

Andrew Schorr, Esther Schorr, Rafael Fonseca, MD, FACP, Krina Patel, MD, MSc

FDA Approves First CAR T-Cell Therapy for Multiple Myeloma

Can Older Patients with Multiple Myeloma Stop Taking Steroids?

Advances in Treating Relapsed Multiple Myeloma

James R. Berenson, MD, Alberto Bessudo, MD, Jack Aiello

First-Line Treatment Options & Side Effects

James R. Berenson, MD, Alberto Bessudo, MD, Jack Aiello

Cancer News Sent to You

Get e-Newsletters with the most current information about your health condition sent to your email!

Sign Up